Hemophilia without prophylaxis: Assessment of joint range of

Abstracts - 2019 - Haemophilia - Wiley Online Library

A Molecular Revolution in the Treatment of Hemophilia: Molecular Therapy

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies - ScienceDirect

Real-world treatment, clinical outcomes and healthcare resource utilization among persons with hemophilia A by age

Ultrasound Assessment of the Joint Status in Hemophilia Patients under Prophylaxis Using the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) Score - ISTH Congress Abstracts

Frontiers Exploration of the minimum necessary FVIII level at different physical activity levels in pediatric patients with hemophilia A

Magnetic resonance imaging in boys with severe hemophilia A: Serial and end‐ of‐study findings from the Canadian Hemophilia Primary Prophylaxis Study - Research and Practice in Thrombosis and Haemostasis

PDF) Haemophilia and joint disease: pathophysiology, evaluation and management

Managing Chronic Pain in Patients with Hemophilia

Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults - Research and Practice in Thrombosis